Brief: aTyr Pharma Inc Reports Q3 Loss Per Share Of $0.46
Nov 10 (Reuters) - aTyr Pharma Inc LIFE.O :
* ATYR PHARMA ANNOUNCES THIRD QUARTER 2022 RESULTS AND
PROVIDES
CORPORATE UPDATE
* QTRLY LOSS PER SHARE $0.46
* Q3 EARNINGS PER SHARE VIEW $-0.46 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX9mH43Y
Further company coverage: LIFE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on aTyr Pharma
See all newsBrief: Atyr Pharma Announces Research Collaboration With Montefiore Einstein
U.S. STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
US STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
U.S. STOCKS ON THE MOVE-CoreWeave, Versant Media, BlackBerry
aTyr rises as FDA aligns on late-stage lung disease study plan